The best indicator for Cigna (CI)
We backtested 366 indicators across daily, weekly and hourly charts on real Cigna (CI) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
McGinley Dynamic
On the weekly chart, this is the strongest risk-adjusted edge we found for Cigna (CI) over ~44.3 years — beating buy-and-hold by 4.0% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Cigna (CI) — trailing buy-and-hold by 4.3% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | McGinley Dynamic ✓ | Weekly | 15.6% | 0.66 | -39.9% | 46.9% | 49 | 4.0% |
| 2 | Hull MA 100 Trend ✓ | Weekly | 10.4% | 0.66 | -37.6% | 56.7% | 60 | -1.2% |
| 3 | Williams %R (50) ✓ | Daily | 12.0% | 0.64 | -43.0% | 39.6% | 303 | 0.2% |
| 4 | DEMA 10/30 Cross ✓ | Weekly | 11.8% | 0.64 | -45.6% | 58.7% | 63 | 0.2% |
| 5 | Geometric MA ✓ | Weekly | 10.8% | 0.63 | -39.2% | 50.5% | 99 | -0.8% |
| 6 | TRIMA 100 Trend ✓ | Daily | 10.3% | 0.62 | -38.6% | 46.2% | 145 | -1.5% |
| 7 | Ulcer Index ✓ | Weekly | 9.6% | 0.62 | -37.3% | 59.3% | 59 | -2.1% |
| 8 | Std Error Channel ✓ | Weekly | 10.5% | 0.61 | -46.9% | 50.0% | 78 | -1.2% |
| 9 | McGinley 100 Trend ✓ | Daily | 13.6% | 0.6 | -54.6% | 44.4% | 72 | 1.8% |
| 10 | Zero-Lag EMA Cross ✓ | Weekly | 11.0% | 0.6 | -58.9% | 59.2% | 103 | -0.7% |
| 11 | ZLEMA 10/30 Cross ✓ | Weekly | 11.0% | 0.6 | -58.9% | 59.2% | 103 | -0.7% |
| 12 | Chande Kroll Stop ✓ | Weekly | 12.6% | 0.59 | -47.8% | 48.7% | 113 | 0.9% |
| 13 | Cascade Z-Score ✓ | Weekly | 9.8% | 0.59 | -37.5% | 59.7% | 62 | -1.8% |
| 14 | ZLEMA 200 Trend ✓ | Daily | 9.3% | 0.58 | -34.6% | 45.4% | 282 | -2.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Cigna (CI), McGinley Dynamic on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.